A high-purity research peptide supplied as a ready-prepared pen for laboratory and analytical use

Tirzepatide 30 mg from SEMPICA HEALTHCARE is supplied as a laboratory-prepared, pre-mixed research product, intended solely for research and development purposes. It is provided in a sealed pen format to offer a consistent, clearly defined alternative to vial-based peptide products.

This product is not a medicine, not a treatment, and not supplied with instructions or advice on use. By purchasing, you accept full responsibility for how the product is handled, stored, and applied within your own research setting.

What Tirzepatide Is – Explained Simply

Tirzepatide is a synthetic peptide compound that has been widely studied because it interacts with more than one metabolic signalling pathway. In simple terms, this means researchers are interested in it because it affects multiple biological signals at the same time, rather than acting on just one.

This makes Tirzepatide more complex than many other peptides and one of the reasons it has attracted such intense academic and scientific attention in recent years.

Why Tirzepatide Is So Widely Studied

Tirzepatide has been studied extensively in relation to metabolic research and weight-related research models, with several large, independently published studies reporting exceptionally high levels of body-weight reduction in participants, in some cases averaging around 20% or more over extended study periods.

These reported results are frequently referenced in scientific journals, academic discussions, and public reporting, which is why Tirzepatide has become one of the most talked-about compounds in modern metabolic research.

It is important to be absolutely clear:

• These results come from external studies, not from SEMPICA
• They are mentioned only to explain scientific interest
• They do not relate to this product being sold
• No outcomes are implied, promised, or suggested

SEMPICA HEALTHCARE does not sell Tirzepatide for weight loss, metabolic treatment, or any form of human application.

Research Focus Areas

In laboratory and analytical settings, Tirzepatide is studied to better understand:

• Metabolic signalling pathways
• Dual-pathway receptor interaction
• How complex peptides influence biological signals
• Molecular stability and degradation behaviour
• Differences between single-pathway and multi-pathway peptides

All research involving this product is observational and investigative, not practical or therapeutic.

Why the SEMPICA Format Matters

Many peptide sellers offer Tirzepatide only as a dry powder in a vial, requiring the buyer to decide how to prepare it, what to mix it with, and how to ensure accuracy. This introduces variability and uncertainty before research even begins.

SEMPICA HEALTHCARE supplies Tirzepatide 30 mg as:

• A laboratory-prepared solution
• Pre-mixed in a fixed volume of bacteriostatic water
• Supplied in a sealed precision pen
• Clearly labelled with known content and volume

This does not change what Tirzepatide is.
It simply removes unnecessary preparation variables.

Technical Information

Compound name: Tirzepatide
Category: Dual-pathway regulatory peptide analogue
CAS number: 2023788-19-2
Molecular formula: C₂₂₅H₃₄₈N₄₈O₆₈
Molecular weight: Approximately 4,814 Da
Purity: ≥ 99%

Net content: 30 mg
Solvent: 3 ml bacteriostatic water
Appearance: Clear liquid
Solution colour: Clear
Format: Factory-sealed research pen

This information is provided so buyers know exactly what the product is, not what to do with it.

What Is Included

Each Tirzepatide 30 mg Research Pen System includes:

• One pre-mixed Tirzepatide 30 mg research pen
• Individually sealed microneedles (for research handling only)
• Alcohol swabs
• Printed storage and handling notes

No usage instructions, protocols, or personalised guidance are provided.

Storage and General Handling Notes

• Store refrigerated when not in use
• Do not freeze
• Avoid exposure to sunlight or UV light
• Keep sealed when not being handled
• Inspect visually before handling; solution should remain clear

These notes are provided only to preserve the material, not as instructions for use.

Combining With Other Research Products

Some researchers choose to study Tirzepatide alongside other peptides to explore broader signalling behaviour. Products commonly purchased at the same time include MOTS-C, AOD-9604, Cagrilinitide, SS-31, GHK-CU, and BPC-157.

SEMPICA HEALTHCARE does not recommend combinations or provide guidance. Any such decisions are entirely the buyer’s responsibility.

Why Researchers Choose SEMPICA HEALTHCARE

Many small peptide websites sell vials with minimal explanation and little long-term accountability. They focus on the sale, not clarity.

SEMPICA HEALTHCARE focuses on:

• Clearly described research products
• Laboratory-prepared solutions
• Consistent presentation and labelling
• Straightforward, factual information

Our role is to supply the product — not to advise, instruct, or influence how it is used.

Important Notice – Please Read Carefully

This product is supplied strictly for research and development purposes only.

It is not intended to:

• Diagnose, treat, cure, or prevent any disease
• Be used on or by humans or animals
• Be considered a medicine, supplement, or injectable product

SEMPICA HEALTHCARE provides no guidance, plans, protocols, or advice beyond the information published on this page.
By purchasing, you confirm that you alone are responsible for use, storage, handling, and regulatory compliance.

Buy Tirzepatide 30 mg Research Pen